Lindbrook Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-409
| Closed | -$16.1K | – | 2895 |
|
2023
Q2 | $16.1K | Sell |
409
-15,932
| -97% | -$627K | ﹤0.01% | 1206 |
|
2023
Q1 | $398K | Sell |
16,341
-102
| -0.6% | -$2.48K | 0.05% | 203 |
|
2022
Q4 | $352K | Buy |
16,443
+309
| +2% | +$6.62K | 0.04% | 221 |
|
2022
Q3 | $289K | Buy |
16,134
+44
| +0.3% | +$788 | 0.05% | 215 |
|
2022
Q2 | $155K | Buy |
16,090
+115
| +0.7% | +$1.11K | 0.03% | 345 |
|
2022
Q1 | $269K | Hold |
15,975
| – | – | 0.04% | 238 |
|
2021
Q4 | $267K | Buy |
15,975
+15,175
| +1,897% | +$254K | 0.04% | 244 |
|
2021
Q3 | $13K | Buy |
+800
| New | +$13K | ﹤0.01% | 911 |
|
2020
Q3 | – | Sell |
-2,000
| Closed | -$10K | – | 1876 |
|
2020
Q2 | $10K | Buy |
+2,000
| New | +$10K | ﹤0.01% | 845 |
|
2020
Q1 | – | Sell |
-3,000
| Closed | -$26K | – | 1912 |
|
2019
Q4 | $26K | Buy |
+3,000
| New | +$26K | 0.01% | 651 |
|